Parma
Italy
19
2025-08-28
The entities that hold a legal rights for patent applications filed by inventor Biagetti Matteo:
Matteo Biagetti from Parma, IT has applied for patents for these inventions. The list has both pending applications and granted patents:
IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS
#2 | 2024-06-13PYRIDO OXAZINE AMINO DERIVATIVES AS ALK5 INHIBITORS
#3 | 2024-04-11PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS
#4 | 2024-04-11PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS
#5 | 2024-01-25AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
#6 | 2024-01-18PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS
#7 | 2024-01-04PHTHALAZINE DERIVATIVES AS P2X3 INHIBITORS
#8 | 2023-12-28(AZA)QUINOLINE 4-AMINES DERIVATIVES AS P2X3 INHIBITORS
#9 | 2023-07-06PYRIDOPYRIMIDINES DERIVATIVES AS P2X3 INHIBITORS
#10 | 2023-03-23AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
#11 | 2022-07-28PYRIDOPYRIMIDINES DERIVATIVES AS P2X3 INHIBITORS
#12 | 2022-07-21AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
#13 | 2022-06-09ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS
#14 | 2017-08-10Pyrazole derivatives as phosphoinositide 3-kinases inhibitors
#15 | 2016-10-20Chromene derivatives as phoshoinositide 3-kinases inhibitors
#16 | 2016-03-17Pyridazinone derivatives as phoshoinositide 3-kinases inhibitors
#17 | 2015-12-17Indolizine derivatives as phoshoinositide 3-kinases inhibitors
#18 | 2015-06-18Isochromene derivatives as phoshoinositide 3-kinases inhibitors
#19 | 2013-02-21Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity
100197 ⎘